Carotid remodeling in hypertension in Kazakh population: phenotype/genotype, possibility to change the disease management

arterial hypertension, remodeling of the cardiovascular system, gene polymorphisms, Kazakh population

1. Micheu M. M., Scarlatescu A. I., Tautu O. F. et al. Molecular markers in arterial hypertension // J. Hypertens. Res. 2016. Vol. 2, № 2. P. 52–60.

2. Semplicini А., Grandi Т., Sandona С. et al. G-Protein b3-Subunit Gene C825T Polymorphism and Cardiovascular Risk: An Updated Review // High Blood Press. Cardiovasc. Prev. 2015. Vol. 22, № 3. P. 225–232.

3. Gu S. J., Guo Z. R., Zhou Z. Y. et al. PРARα and PPARγ polymorphisms as risk factors for dyslipidemia in a Chinese Han population // Lipids Health Dis. 2014. Vol. 13. P. 23.

4. Kolovou V., Lagou E., Mihas C. еt al. Angiotensinogen (AGT) M235T, AGT T174M and Angiotensin-1-Converting Enzyme (ACE) I/D Gene Polymorphisms in Essential Hypertension: Effects on Ramipril Efficacy // Cardiovasc. Med. J. 2015. Vol. 9. P. 118–126.

5. Li W. X., Dai S. X., Zheng J. J. et al. Homocysteine Metabolism Gene Polymorphisms (MTHFR C677T, MTHFR A1298C, MTR A2756G and MTRR A66G) Jointly Elevate the Risk of Folate Deficiency // Nutrients. 2015. Vol. 7, № 8. P. 6670–6687.

6. Wu S., Hsu L. A., Teng M. S. et al. Interactive effects of C-reactive protein levels on the association between APOE variants and triglyceride levels in a Taiwanese population // Lipids Health Dis. 2016. Vol. 15. P. 94.

7. Чернявина А. И., Суровцева М. В. Вклад полиморфизма генов сердечно-сосудистого риска в развитие артериального ремоделирования в зависимости от наличия артериальной гипертензии // Российский кардиологический журнал. 2018. № 1 (153). С. 43–50.